Skip to main content
Skip to content
Case File
efta-efta02022732DOJ Data Set 10Correspondence

EFTA Document EFTA02022732

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta02022732
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
To: jeevacationtegmail.com[jeevaeation@gmail.com]; Jeffrey Epstein[eevacation@gmail.com] From: George Church Sent: Fri 11/18/2011 2:56:16 PM Subject: RE: Yes. I'm working toward this goal fairly rapidly, but trying to do so in a way that minimizes risk to the field. James Wilson (who happened to be my physician, in the 1990s) set back the field of gene therapy by a decade by rushing. http:llwww.scientificamerican.com/article.efm?id=gene-therapv-an-interview My lab is good at conceiving of radically new technologies as well as improving throughput and quality by factors of ten. Given a couple of years and decent funding, this would become much more reasonable. I'm too busy dong it well to get distracted by trying to do it badly. -- George From: Jeffrey Epstein [mailto:jeevacation@gmail.com] Sent: Friday, November 18, 2011 9:21 AM sorry, you can;t make it, . did the cloning isssue , give you pause? EFTA_R1_00529083 EFTA02022732

Technical Artifacts (5)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Domainjeevacationtegmail.com
Domainllwww.scientificamerican.com
Emaileevacation@gmail.com
Emailjeevacation@gmail.com
Emailjeevaeation@gmail.com

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.